Jamia Millia Islamia
11
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
SCN9A Gene Expression and Inflammatory Cytokines
Role: lead
Single Gene Polymorphism and the Success Rate of Inferior Alveolar Nerve Block
Role: lead
Effect of Menstrual Phase on the Anesthetic Efficacy
Role: lead
Effect of Alcohol Consumption on the Success Rates
Role: lead
Intraligamentary Injections and Post-endodontic Pain
Role: lead
Effect of Intrapulpal Injections on the Post-endodontic Pain
Role: lead
Oral Health Related Quality of Life and Clinical Outcomes in Patients Undergoing Canine Disimpaction
Role: lead
Stretching Techniques of Knee Muscles and Their Effect on Joint Range, Suppleness and Muscle Activity in Elderly
Role: collaborator
Use of Tramadol Intraligamentary Injections
Role: lead
Evaluation of the Effect of Adding Dexamethasone to 2% Lidocaine
Role: lead
Post - Activation Potentiation After Plyometric and Heavy Resistance Exercise in Soccer Players
Role: lead
All 11 trials loaded